RecruitingNCT06717165
Brain stimulation added to exposure therapy for obsessive-compulsive symptoms
About this title
Efficacy and Mechanism of Augmentation of Cognitive Behavioral Therapy With Transcranial Alternating Current Stimulation(tACS) for Obsessive-Compulsive Disorder (OCD)
Read the official source — NCT06717165Interventional studyAges 18–60ChinaOCD
Understand this study
Who could participate?
Listed age limits: 18 years to 60 years.
- Listed locations
- ShanghaiSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 15, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 62
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Combination product
- Locations
- China
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT06717165
- Official title
Show the full official title
A Randomized, Double-Blind, Clinical Trial to Study the Efficacy and Mechanisms of Transcranial Alternating Current Stimulation (tACS) Concurrent With Exposure-based Cognitive-Behavioral Therapy (CBT) for Obsessive-Compulsive Disorder (OCD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Shanghai
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
